Skip to main content

Day: February 15, 2024

Employers Holdings, Inc. Reports Fourth Quarter 2023 and Full-Year Financial Results; Declares Quarterly Cash Dividend of $0.28 per Share

Company to Host Conference Call on Friday, February 16, 2024, at 11:00 a.m. Eastern Standard Time HENDERSON, Nev., Feb. 15, 2024 (GLOBE NEWSWIRE) — Employers Holdings, Inc. (the “Company”) (NYSE:EIG), a holding company with subsidiaries that are specialty providers of workers’ compensation insurance and services focused on select, small businesses engaged in low-to-medium hazard industries, today reported financial results for its fourth quarter and year ended December 31, 2023. Full-Year 2023 Financial Highlights(All comparisons versus full-year 2022)Net income of $118.1 million ($4.45 per diluted share), versus $48.4 million ($1.75 per diluted share); Adjusted net income of $101.7 million ($3.83 per diluted share), versus $81.0 million ($2.93 per diluted share); Net investment income of $106.5 million, versus $89.8 million; Gross...

Continue reading

Elme Communities Announces Fourth Quarter and Full Year 2023 Results

BETHESDA, Md., Feb. 15, 2024 (GLOBE NEWSWIRE) — Elme Communities (the “Company”) (NYSE: ELME), a multifamily REIT with communities in the Washington, DC metro area and the Atlanta metro area, reported financial and operating results today for the quarter and year ended December 31, 2023: Full-Year 2023 Financial and Operational ResultsNet loss was $53.0 million, or $0.61 per diluted share NAREIT FFO was $77.8 million, or $0.88 per diluted share, up 27.9% compared to the prior year Core FFO was $85.2 million, or $0.97 per diluted share, up 10.2% compared to the prior year Net Operating Income (NOI) was $148.1 million, up 9.4% compared to the prior year Same-store multifamily NOI increased by 8.3% compared to the prior year period Average Effective Monthly Rent per Home increased 6.5% compared to the prior year for our Same-Store...

Continue reading

Casella Waste Systems, Inc. Announces Fourth Quarter and Fiscal Year 2023 Results and Provides Fiscal Year 2024 Guidance

Caps milestone year of growth in 2023.RUTLAND, Vt., Feb. 15, 2024 (GLOBE NEWSWIRE) — Casella Waste Systems, Inc. (NASDAQ: CWST), a regional solid waste, recycling and resource management services company, today reported its financial results for the three and twelve month periods ended December 31, 2023. The Company also provided guidance for the fiscal year ending December 31, 2024 (“fiscal year 2024”). Highlights for the Three Months and Twelve Months Ended December 31, 2023: Revenues were $359.6 million for the quarter, up $87.4 million, or up 32.1%, from the same period in 2022. Revenues were $1.265 billion for the fiscal year ended December 31, 2023 (“fiscal year 2023”), up $179.5 million, or up 16.5%, from the fiscal year ended December 31, 2022 (“fiscal year 2022”). Overall solid...

Continue reading

Grupo Bafar Reports Fourth Quarter 2023 Results

CHIHUAHUA, Mexico, Feb. 15, 2024 (GLOBE NEWSWIRE) — Grupo Bafar, S.A.B de C.V. (BMV: BAFARB), a recognized leader in the Mexican food sector, has announced its results for the fourth quarter of 2023, highlighting solid growth in its main divisions. Results for the Fourth Quarter of 2023 Net sales amounted to $6,925.0 million pesos. Gross profit increased 41.7% with a margin of 31.0%. Operating income increased 40.7%, and EBITDA increased 25.1%. During the fourth quarter of 2023, Grupo Bafar reaffirms its position as one of the leading food companies in Mexico, consolidating four decades of business success. The company stands out in this period thanks to its solid and steady growth in operating results and financial margins, evidencing solid and strategic management. These achievements not only underscore Grupo Bafar’s ability...

Continue reading

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update

MENLO PARK, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today reported its results for the quarter and year ended December 31, 2023. Financial ResultsFourth quarter revenue of $135.4 million, a 31 percent increase over the same period in 2022 Full year 2023 revenue of $482.4 million, a 20 percent increase over 2022 Reiterated 2024 revenue guidance of $600 – $630 million Fourth quarter net income of $31.4 million, compared to $16.6 million in fourth quarter 2022 2023 net income of $106.1 million, compared to $101.4 million in 2022 Cash and investments of $425.4 million as...

Continue reading

Backblaze Announces Fourth Quarter and Full Year 2023 Financial Results

47% Revenue Growth in B2 Cloud Storage, 25% Revenue Growth Overall in Q4 2023 SAN MATEO, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) — Backblaze, Inc. (Nasdaq: BLZE), a leading specialized storage cloud platform, today announced results for its fourth quarter and year ended December 31, 2023. “Backblaze capped off a strong finish to the year with our B2 Cloud Storage revenue growing 47% in Q4 and delivered adjusted EBITDA profitability for the first time as a public company,” said Gleb Budman, CEO of Backblaze. “We exited 2023 with accelerated revenue growth and dramatically improved profitability and cash usage metrics. I’m excited for the coming year as Backblaze continues to move up in the mid-market and help customers who are poorly served by legacy solutions to break free with our differentiated cloud services.” Fourth Quarter...

Continue reading

Trupanion Reports Fourth Quarter & Full Year 2023 Results

Subscription revenue growth accelerated while margins continued to expand sequentiallyTrupanion, Inc.Total Revenue by QuarterSEATTLE, Feb. 15, 2024 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2023.   The financial results are preliminary and subject to completion of the Company’s audit as described below.    “I am pleased that Q4 showed continued improvement in our financial metrics,” said Darryl Rawlings, CEO and Chair of the Board. “The combination of accelerated subscription revenue growth, continued margin expansion and efficient acquisition spend drove another quarter of positive free cash flow.” Fourth Quarter 2023 Financial and Business HighlightsTotal revenue...

Continue reading

Opendoor Announces Fourth Quarter and Full Year 2023 Financial Results

SAN FRANCISCO, Feb. 15, 2024 (GLOBE NEWSWIRE) — Opendoor Technologies Inc. (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today reported financial results for its fourth quarter and year ended December 31, 2023. Opendoor’s fourth quarter and year-end 2023 financial results and management commentary can be accessed through the Company’s shareholder letter on the “Quarterly Reports” page of Opendoor’s investor relations website at https://investor.opendoor.com. “The past year was about focus, execution, and progress. Our fourth quarter results exceeded the high end of our prior guidance ranges, demonstrating our ability to deliver, despite ongoing uncertainty in the housing market. We increased our home acquisitions sequentially throughout the year, built a new book of inventory that is performing...

Continue reading

Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

SAN CARLOS, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today that it will report financial results for the fourth quarter and full year 2023 after market close on February 27, 2024. Company management will host a conference call and webcast beginning at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a business update. To participate in the conference call, please dial (800) 225-9448 (domestic) or (203) 518-9708 (international) and refer to conference ID PCVXQ423. A live webcast of the conference call will also be available on the investor relations page of the Vaxcyte corporate website at www.vaxcyte.com. After the...

Continue reading

NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

MOUNTAIN VIEW, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year 2023 after market close on Tuesday, March 5, 2024. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https://edge.media-server.com/mmc/p/p69edqps. Individuals interested in participating in the call via telephone may access the call by dialing +1-888-886-7786 and referencing Conference ID 91932269. The webcast will be archived on the company’s investor...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.